SPY735.46 QQQ659.26 BTC/USD75,733.00−0.31%DIA509.52 GLD369.94 TLT81.84

Premium Services

Premium Services

Core Laboratories Inc

CLBNYSE

Trade with Public

Trade with Public

$8.93

N/A

Last update: Nov 5, 4:00 PM

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Dividends Compare Options Stock Report

Connect With Us

About Benzinga

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Core Laboratories (CLB) Stock Price Target 2026 & Analyst Forecast - Benzinga

Core Laboratories (CLB) Stock Price Target 2026

The average analyst price target for Core Laboratories is $14.25, 59.6% above the current price. Of 4 analysts, 3 rate it Hold and 1 Sell. Targets range from $12 to $17. The latest change came on Jul 16, 2025, when Stifel lowered its price target on Core Laboratories from $13 to $12 and kept a Hold rating.

The Average Analyst Price Target for Core Laboratories is $14.25.

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

3Hold

1Sell

Consensus RatingNeutral# Analysts4Avg. Consensus PT$14.25Upside to Avg. PT+59.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Core Laboratories Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 16, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$13→$12
May 13, 2025	Citigroup	Scott Gruber	PT Cut	Neutral	$16→$13
Apr 15, 2025	Stifel	Stephen Gengaro	PT Cut	Hold	$19→$15
Mar 12, 2025	Citigroup	Scott Gruber	Upgrade	Sell→Neutral	$15→$16
Feb 20, 2025	Citigroup	Scott Gruber	PT Raise	Sell	$14→$15
Oct 31, 2024	Citigroup	Scott Gruber	PT Cut	Sell	$15→$14
Jul 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$18→$22
Jul 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$16→$15
Jul 15, 2024	Piper Sandler	Luke Lemoine	PT Cut	Neutral	$18→$17
Apr 26, 2024	Stifel	Stephen Gengaro	PT Raise	Hold	$17→$18
Apr 15, 2024	B of A Securities	Chase Mulvehill	PT Cut	Underperform	$17→$16
Feb 5, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$21→$17
Jan 29, 2024	Stifel	Stephen Gengaro	PT Cut	Hold	$23→$21

Analyst Ratings News

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $12

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $13 to $12.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Core Laboratories, Lowers Price Target to $15

Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $19 to $15.

Benzinga Newsdesk

PRO
Citigroup Upgrades Core Laboratories to Neutral, Raises Price Target to $16

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Raises Price Target to $15

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and raises the price target from $14 to $15.

Benzinga Newsdesk

PRO
Citigroup Maintains Sell on Core Laboratories, Lowers Price Target to $14

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Sell and lowers the price target from $15 to $14.

Benzinga Newsdesk